Our Service
Production Excellence
Our approach is rooted in innovation, scientific rigor, and a dedication to excellence. We have assembled a dynamic team of experts who share a common purpose: to develop and manufacture CGT solutions that not only meet regulatory standards but also push the boundaries of what is possible in healthcare towards regenerative medicine.
Innovation
Scientific Rigor
Pushing Boundaries
Production Services
We provide cGMP-grade production services for a range of allogeneic and autologous cell and gene therapy products.
- Mesenchymal Stem cells
Allogeneic (umbilical cord derived) mesenchymal stem cells at the centre of research into regenerative and rejuvenative therapies for diverse medical conditions including osteoarthritis and critical limb ischaemia. - Exosomes
Allogeneic (UC-MSC derived) exosomes to facilitate research in cell-to-cell communication and tissue repair for clinical applications in regenerative medicine, drug delivery, and disease diagnostics.
- CytokinesVital
signalling proteins to support research into the regulation of immune responses, inflammation, and cell growth, for clinical applications in the treatment of autoimmune diseases, cancer, and various inflammatory conditions. - NK cells
Autologous natural killer cells for research into immune response involving the targeting and destroying of cancer cells and virally infected cells, offering promising therapeutic potential in oncology and infectious diseases. - NK T-cells
Combining the properties of autologous natural killer and T cells, NKT cells support research into immune defence, offering therapeutic potential in cancer treatment, autoimmune diseases, and infections. - CAR NK
Engineered to target specific cancer cells, allogeneic CAR NK cells enhance the natural killing ability of NK cells, offering a powerful research into this innovative approach to cancer immunotherapy. - CAR T-cells
Genetically engineered to target cancer cells, autologous CAR T cells offer a revolutionary approach in immunotherapy research, with the ultimate goal of enabling personalized and highly effective treatment options for a range of cancers. - Others
Let us know what you are looking for by emailing enquiries at Contact Us
CDMO Services
Spanning over 10,000 square feet, our cutting-edge production facility is specifically designed to meet the rigorous standards of cGMP. The facility equipment is equipped with multiple cleanrooms and cryopreservation rooms , all staffed by teams of experienced scientists, engineers, and laboratory technicians
The production of cell and gene therapies requires precision and control, which often involves proprietary knowledge and expertise. For most GMP labs, this limits the ability to scale production. Fortunately, the Celler production facility is designed to accommodate both small, focussed research and large-scale production, allowing for seamless scale-up from research to commercial levels.
Conveniently located within driving distance of Kuala Lumpur’s major hospitals and less than an hour away from Malaysia’s international airport, our facility offers easy access to Southeast Asia’s major capital cities via short flights, making it an ideal location for regional distribution and collaboration.
Conveniently located within driving distance of Kuala Lumpur’s major hospitals and less than an hour away from Malaysia’s international airport, our facility offers easy access to Southeast Asia’s major capital cities via short flights, making it an ideal location for regional distribution and collaboration.
Market Access Services
In addition to contract development and manufacturing services, our market access services are designed to help foreign biopharmaceutical companies enter Southeast Asia. These services include the following.
Regulatory Affairs and ComplianceRegulatory Strategy Development
Submission and Approval Management
Regulatory Liaison
Regulatory Affairs and Compliance
Market Entry Strategy
Market Research and Analysis
Pricing and Reimbursement Strategies
Health Technology Assessment (HTA) Support
Distribution and Supply Chain ManagementLogistics and Distribution Planning
Inventory Management
Commercialization Support
Sales and Marketing StrategyKey Opinion Leader Engagement
Training and Education
Pharmacovigilance and Post-Market SurveillanceSafety Monitoring
Risk Management Plans
Regulatory and Market Intelligence
Monitoring Regulatory Changes
Competitor Analysis
Patient Access Programs
Quality Assurance and ControlCompliance Audits
Quality Management Systems
Distribution and Supply Chain Management
Sales and Marketing Strategy
Pharmacovigilance and Post-Market Surveillance
Quality Assurance and Control
